HAMBURGER; Agnes Eva
Patent Applications and Registrations
Patent applications and USPTO patent grants for HAMBURGER; Agnes Eva.The latest application filed is for "pac1 antibodies and uses thereof".
Company Profile
10.31.29
- HAMBURGER; Agnes Eva - Newbury Park CA
- - Newbury Park CA US
- Hamburger; Agnes Eva - Thousand Oaks CA
Patent Activity
| Patent | Date |
|---|---|
| Pac1 Antibodies And Uses Thereof App 20220195022 - AGRAWAL; Neeraj Jagdish ; et al. | 2022-06-23 |
| Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof Grant 11,248,043 - Agrawal , et al. February 15, 2 | 2022-02-15 |
| Fg21 Mutants And Uses Thereof App 20210317176 - Belouski; Edward John ; et al. | 2021-10-14 |
| Methods of treating non-alcoholic steatohepatitis using FGF21 mutants Grant 11,072,640 - Belouski , et al. July 27, 2 | 2021-07-27 |
| Growth Differentiation Factor 15 (gdf-15) Constructs App 20210079051 - XIONG; Yumei ; et al. | 2021-03-18 |
| Pac1 Antibodies And Uses Thereof App 20210017261 - AGRAWAL; Neeraj Jagdish ; et al. | 2021-01-21 |
| Growth differentiation factor 15 (GDF-15) constructs Grant 10,894,814 - Xiong , et al. January 19, 2 | 2021-01-19 |
| Human PAC1 antibodies Grant 10,793,631 - Xu , et al. October 6, 2 | 2020-10-06 |
| PAC1 antibodies and uses thereof Grant 10,738,110 - Agrawal , et al. A | 2020-08-11 |
| Human Pac1 Antibodies App 20200172614 - XU; Cen ; et al. | 2020-06-04 |
| Human PAC1 antibodies Grant 10,472,417 - Xu , et al. Nov | 2019-11-12 |
| Growth Differentiation Factor 15 (GDF-15) Polypeptides App 20190315822 - XIONG; Yumei ; et al. | 2019-10-17 |
| Pac1 Antibodies And Uses Thereof App 20190218279 - AGRAWAL; Neeraj Jagdish ; et al. | 2019-07-18 |
| Growth differentiation factor 15 (GDF-15) polypeptides Grant 10,336,798 - Xiong , et al. | 2019-07-02 |
| Human PAC1 antibodies Grant 10,294,298 - Xu , et al. | 2019-05-21 |
| FGF21 Mutants and Uses Thereof App 20190023757 - Belouski; Edward John ; et al. | 2019-01-24 |
| Human Pac1 Antibodies App 20180362645 - XU; Cen ; et al. | 2018-12-20 |
| Human PAC1 antibodies Grant 10,053,507 - Xu , et al. August 21, 2 | 2018-08-21 |
| Methods of treating of diabetes and obesity using FGF21 mutants Grant 10,011,642 - Belouski , et al. July 3, 2 | 2018-07-03 |
| Human Pac1 Antibodies App 20180094055 - XU; Cen ; et al. | 2018-04-05 |
| Growth Differentiation Factor 15 (gdf-15) Constructs App 20180079790 - XIONG; Yumei ; et al. | 2018-03-22 |
| Growth differentiation factor 15 (GDF-15) constructs Grant 9,862,752 - Xiong , et al. January 9, 2 | 2018-01-09 |
| Human PAC1 antibodies Grant 9,822,178 - Xu , et al. November 21, 2 | 2017-11-21 |
| Growth Differentiation Factor 15 (GDF-15) Polypeptides App 20170291929 - XIONG; Yumei ; et al. | 2017-10-12 |
| Human Pac1 Antibodies App 20170247451 - XU; Cen ; et al. | 2017-08-31 |
| Growth differentiation factor 15 (GDF-15) polypeptides Grant 9,714,276 - Xiong , et al. July 25, 2 | 2017-07-25 |
| Human PAC1 antibodies Grant 9,676,851 - Xu , et al. June 13, 2 | 2017-06-13 |
| FGF21 mutants comprising a mutation at position 98, 171 and/or 180 Grant 9,493,530 - Belouski , et al. November 15, 2 | 2016-11-15 |
| Human Pac1 Antibodies App 20160251432 - XU; Cen ; et al. | 2016-09-01 |
| Growth Differentiation Factor 15 (gdf-15) Constructs App 20160168213 - XIONG; Yumei ; et al. | 2016-06-16 |
| Fgf Mutants And Uses Thereof App 20160168223 - Belouski; Edward John ; et al. | 2016-06-16 |
| Human PAC1 antibodies Grant 9,365,653 - Xu , et al. June 14, 2 | 2016-06-14 |
| FGF mutants with reduced proteolysis and aggregation Grant 9,273,106 - Belouski , et al. March 1, 2 | 2016-03-01 |
| Human Pac1 Antibodies App 20160039939 - XU; Cen ; et al. | 2016-02-11 |
| Human Pac1 Antibodies App 20150010560 - XU; Cen ; et al. | 2015-01-08 |
| Growth Differentiation Factor 15 (gdf-15) Polypeptides App 20140378665 - Xiong; Yumei ; et al. | 2014-12-25 |
| Fgf21 Mutants And Uses Thereof App 20140323396 - Belouski; Edward John ; et al. | 2014-10-30 |
| FGF21 polypeptides comprising two or more mutations and uses thereof Grant 8,835,385 - Belouski , et al. September 16, 2 | 2014-09-16 |
| FGF 21 polypeptides comprising two or more mutations and uses thereof Grant 8,795,985 - Belouski , et al. August 5, 2 | 2014-08-05 |
| FGF21 mutant fusion polypeptides and uses thereof Grant 8,642,546 - Belouski , et al. February 4, 2 | 2014-02-04 |
| FGF21 mutants multimers and uses thereof Grant 8,618,053 - Belouski , et al. December 31, 2 | 2013-12-31 |
| FGF21 mutants multimers and uses thereof Grant 08618053 - | 2013-12-31 |
| FGF21 mutants and uses thereof Grant 8,410,051 - Belouski , et al. April 2, 2 | 2013-04-02 |
| Uses of FGF21 polypeptides comprising two or more mutations Grant 8,361,963 - Belouski , et al. January 29, 2 | 2013-01-29 |
| Fgf21 Mutants And Uses Thereof App 20120213779 - Belouski; Edward John ; et al. | 2012-08-23 |
| Fgf21 Mutants And Uses Thereof App 20120178685 - BELOUSKI; EDWARD JOHN ; et al. | 2012-07-12 |
| Fgf21 Mutants And Uses Thereof App 20120177646 - Belouski; Edward John ; et al. | 2012-07-12 |
| FGF21 mutants and uses thereof Grant 8,188,040 - Belouski , et al. May 29, 2 | 2012-05-29 |
| Fgf21 Mutants And Uses Thereof App 20120093815 - BELOUSKI; EDWARD JOHN ; et al. | 2012-04-19 |
| Fgf21 Mutants And Uses Thereof App 20120087920 - Belouski; Edward John ; et al. | 2012-04-12 |
| Fgf21 Mutants And Uses Thereof App 20120052069 - Belouski; Edward John ; et al. | 2012-03-01 |
| Fgf21 Mutants And Uses Thereof App 20120003216 - BELOUSKI; EDWARD JOHN ; et al. | 2012-01-05 |
| FGF21 polypeptides comprising two or more mutations Grant 8,034,770 - Belouski , et al. October 11, 2 | 2011-10-11 |
| Fgf21 Mutants And Uses Thereof App 20100285131 - Belouski; Edward John ; et al. | 2010-11-11 |
| FGF21 Mutants and uses thereof App 20090305986 - Belouski; Edward John ; et al. | 2009-12-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 